Latest Transplantation medicine Stories

RESEARCH TRIANGLE PARK, N.C., Feb. 4, 2013 /PRNewswire/ -- Chimerix, Inc., a biopharmaceutical company developing antivirals in areas of high unmet medical need, today announced that three abstracts related to the broad-spectrum antiviral compound CMX001 will be presented at the BMT Tandem Meetings being held February 13-17 in Salt Lake City. The BMT Tandem Meetings are the combined annual meetings of the Center for International Blood & Marrow Transplant Research (CIBMTR) and...

The gift of donation lives on by advancing the science of medicine CENTENNIAL, Colo., Jan. 29, 2013 /PRNewswire-USNewswire/ -- AlloSource, one of the nation's largest non-profit providers of skin, bone and soft tissue allografts for use in surgical procedures and the world's largest processor of cellular bone allografts, today announced the donation of research tissue to the Steadman Philippon Research Institute (SPRI) in order to further honor the gift of tissue donation. "The...

A new study from Boston University School of Medicine (BUSM) shows that tissues derived from induced pluripotent stem (iPS) cells in an experimental model were not rejected when transplanted back into genetically identical recipients. The study, published online in Cell Stem Cell, demonstrates the potential of utilizing iPS cells to develop cell types that could offer treatment for a wide range of conditions, including diabetes, liver and lung diseases, without the barrier of immune...

A San Francisco Bay Area newlywed couple, Kevin Weston and Lateefah Simon, has started a national effort to register 1,000 African Americans as possible bone marrow donors and find a match for Kevin, who needs to undergo a transplant in less than two months for an extremely rare form of leukemia. (PRWEB) January 18, 2013 PALO ALTO, CALIF. – A San Francisco Bay Area newlywed couple, Kevin Weston and Lateefah Simon, has started a national effort to register 1,000 African Americans as...

TORONTO, Jan. 17, 2013 /PRNewswire/ -- According to Millennium Research Group (MRG), the global authority on medical technology market intelligence, demographic trends and increased acceptance of orthopedic biomaterials in Europe will lead to moderate growth in this market to a total of more than $370 million in 2017. (Logo: http://photos.prnewswire.com/prnh/20130103/MM36799LOGO ) The bone graft substitute (BGS) segment will expand due to increasing product penetration and...

NEW YORK, Jan. 16, 2013 /PRNewswire/ -- On the court, Joe Johnson, star shooting guard for the Brooklyn Nets, is admired for the way he battles his opponents. Off the court, he looks to his mother for inspiration; she is afflicted with leukemia and fighting one of the toughest opponents to beat. (Photo: http://photos.prnewswire.com/prnh/20130116/NY43727) To support her and others battling blood cancers around the globe, the Brooklyn Nets and Delete Blood Cancer DKMS, the...

HORSHOLM, Denmark, Jan. 3, 2013 /PRNewswire/ -- Veloxis Pharmaceuticals A/S today is announcing that the LCP-Tacro Phase III clinical trial in stable kidney transplant patients, the 3001 study, has been published online in the American Journal of Transplantation. The article reports on the randomized, controlled, multicenter Phase III trial, which demonstrated that LCP-Tacro dosed once-daily was not inferior to the current leading transplant drug, Prograf(®), dosed twice-daily....

A combination of three blood-borne proteins may bolster efforts to prevent graft loss years after transplant BOSTON, Dec. 26, 2012 /PRNewswire-USNewswire/ -- Researchers at Boston Children's Hospital have found a combination of biomarkers related to blood vessel and tissue injury that, when measured together, could signal when a transplanted heart is becoming damaged to the point of failure, a process that is often undetected. The markers would give doctors an opportunity to...

Joe Gutierrez participates in the 2013 Tournament of Roses Parade® showing the country the life-changing impact of tissue donation CENTENNIAL, Colo., Dec. 19, 2012 /PRNewswire-USNewswire/ -- AlloSource, one of the nation's largest non-profit providers of skin, bone and soft tissue allografts for use in surgical procedures and the world's largest processor of cellular bone allografts, announces its seventh annual sponsorship of a tissue recipient float rider aboard the annual Donate...

DENVER, Dec. 12, 2012 /PRNewswire/ -- Donor Alliance, the federally-designated, non-profit organ procurement organization and American Association of Tissue Banks (AATB) accredited tissue bank serving Colorado and most of Wyoming today announced its sponsorship of a float rider from Colorado aboard the annual Donate Life float in the Tournament of Roses Parade®. Peter Lang of Golden was just 16-years-old when his sister Perri Lang lost her life following a car accident, becoming...